Pancreatic Cancer Awareness Month: UCI Health Medical, Surgical, Radiation Clinicians Available to Comment About Pancreatic Cancer, New Treatment Options | Newswise - 足球世界杯

The Food and Drug Administration (FDA)’s recent approval of daraxonrasib, a targeted RAS inhibitor for the most common form of pancreatic cancer, has the potential to improve short-term survival rates for advanced metastatic forms of the cancer. While not a cure, this treatment,